User profiles for Jilong Yang
Jilong Yang, MD, Ph.D.(杨吉龙)Tianjin Medical University Cancer Hospital & Institute Verified email at tjmuch.com Cited by 2557 |
New molecular insights into osteosarcoma targeted therapy
Osteosarcoma is a relatively uncommon cancer, accounting for 5% of childhood cancers
and 8.9% of cancer-related deaths in children. The overall incidence is five cases per million …
and 8.9% of cancer-related deaths in children. The overall incidence is five cases per million …
[HTML][HTML] Histone deacetylase 6 in cancer
…, X Liu, F Song, K Chen, W Zhang, J Yang - Journal of hematology & …, 2018 - Springer
Histone acetylation and deacetylation are important epigenetic mechanisms that regulate
gene expression and transcription. Histone deacetylase 6 (HDAC6) is a unique member of the …
gene expression and transcription. Histone deacetylase 6 (HDAC6) is a unique member of the …
Geochemical and isotopic evidence for palaeo-seawater intrusion into the south coast aquifer of Laizhou Bay, China
This research aims to improve the current knowledge of groundwater salinisation processes
in coastal aquifers using combined hydrochemical and isotopic parameters and inverse …
in coastal aquifers using combined hydrochemical and isotopic parameters and inverse …
[HTML][HTML] Advances in targeted therapy for osteosarcoma
…, M Hao, X Du, K Chen, G Wang, J Yang - Discovery …, 2014 - discoverymedicine.com
Osteosarcoma is an aggressive cancer in skeletal system with unknown molecular mechanisms
of etiology and pathogenesis, therefore it remains a challenge for current therapeutic …
of etiology and pathogenesis, therefore it remains a challenge for current therapeutic …
Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma
BACKGROUND: Osteosarcoma is the most common primary tumor of bone. It is a highly
vascular and extremely destructive malignancy that mainly affects children and young adults. …
vascular and extremely destructive malignancy that mainly affects children and young adults. …
[HTML][HTML] A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma
…, J Wei, J Lu, H Liu, L Xiang, Y Yang, M Yang… - Nature …, 2022 - nature.com
Acral melanoma is a dismal subtype of melanoma occurring in glabrous acral skin, and has
a higher incidence in East Asians. We perform single-cell RNA sequencing for 63,394 cells …
a higher incidence in East Asians. We perform single-cell RNA sequencing for 63,394 cells …
Genetic aberrations in soft tissue leiomyosarcoma
Leiomyosarcoma is a malignant mesenchymal tumor composed of cells showing smooth
muscle differentiation. This tumor usually occurs in middle-aged or older adults, and forms a …
muscle differentiation. This tumor usually occurs in middle-aged or older adults, and forms a …
Distribution, source investigation, and risk assessment of topsoil heavy metals in areas with intensive anthropogenic activities using the positive matrix factorization …
…, L Meng, F Liu, Y Sheng, S Chen, J Yang… - Environmental …, 2023 - Springer
Over the past decade, heavy metal (HMs) contamination in soil environments has become
severe worldwide. However, their resulting ecological and health risks remained elusive …
severe worldwide. However, their resulting ecological and health risks remained elusive …
Genetic aberrations of gastrointestinal stromal tumors
Gastrointestinal stromal tumor (GIST) is the most common mesenchymal neoplasm in the
gastrointestinal tract and is associated with mutations of the KIT or PDGFRA gene. In addition, …
gastrointestinal tract and is associated with mutations of the KIT or PDGFRA gene. In addition, …
[HTML][HTML] Phase I trial of fourth-generation anti-CD19 chimeric antigen receptor T cells against relapsed or refractory B cell non-Hodgkin lymphomas
…, L Deng, C Song, C Yue, Y He, J Yang… - Frontiers in …, 2020 - frontiersin.org
Background The administration of second- or third-generation anti-CD19 chimeric antigen
receptor (CAR) T cells has remarkably improved the survival of patients with relapsed or …
receptor (CAR) T cells has remarkably improved the survival of patients with relapsed or …